6.4.7. observation. unselected relapsing patients median actuarial time development metastasis 8 years median time metastasis death five years . patients eau low-risk bcr features (see section 6.3.3), unfit patients life expectancy less ten years patients unwilling undergo salvage treatment, active follow-up may represent viable option.